← Back to list
Absorbable Nasal Implant for Treatment of Nasal Valve Collapse
Effective date
Not stated in the notice
Identified
Jun 20, 2026
Summary
This BCBS policy considers the insertion of an absorbable lateral nasal implant for symptomatic nasal valve collapse investigational. Under the policy's definition, investigational treatment is not considered medically necessary. The Federal Employee Program may assess FDA-approved devices only on the basis of medical necessity. The policy was reviewed on 04/07/2026 with no changes.
Get alerts when payers change rules like this one
We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.
Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.
What to do
Action · 3 steps
01Billing team: Before billing CPT 30468 or unlisted procedure 30999 for an absorbable lateral nasal implant for nasal valve collapse, check whether the member's plan is Federal Employee Program.
02For Federal Employee Program members, the implant may be assessed only on medical necessity.
03For other members, the policy treats the implant as investigational, and investigational treatment is not considered medically necessary.
Codes mentioned
3046830999
Original notice
Absorbable Nasal Implant for Treatment of Nasal Valve Collapse
bcbsms.com · Always check the source before changing claims.